Navigation Links
OXYMIZER® Pendant Disposable Oxygen-Conserving Device

ProductsOXYMIZER® Pendant Disposable Oxygen-Conserving Device
Company CHAD Therapeutics, Inc.
Item OXYMIZER® Pendant Disposable Oxygen-Conserving Device
Features 
  • Savings of two to four times over continuous flow.
  • Conservation without batteries or controls.
  • Use with all oxygen sources, including the TOTAL O2® Delivery System and standard oxygen concentrators.
  • Adequate saturations at higher flows when used in place of a nonrebreather mask.
  • Proven efficacy while sleeping and during exercise.
  • Built-in humidification effect - no need for supplemental humidification.
  • Oxygen-conserving reservoir in an easy to conceal pendant.
  • Updated look with softer, small cannula tubing and no ear loops.
  • Can be used with pursed-lip breathing for improved oxygen saturations and increased conservation.
    • Description Get the equivalent of 7.5 liters out of your five-liter concentrators.

    No longer will you need two machines for your high-flow patients!

    In many ways, the OXYMIZER Disposable Oxygen-Conserving Devices function like standard conservers, because they extend oxygen duration by reducing the flow of oxygen required to saturate a patient. However, they do not require electronics, batteries, switches, or flow controls. During exhalation, a reservoir contained within the facepiece or pendant fills with oxygen and is then delivered to the patient upon inhalation.

    Oxygen is generally administered via a nasal cannula flowing continuously throughout the respiratory cycle; however, the greatest benefit of oxygen therapy occurs during early inspiration with much of the remaining oxygen lost to the surrounding environment.

    The OXYMIZER® disposable oxygen-conserving devices concentrate oxygen delivery to the initial moment of inspiration, which allows for equivalent saturations at much lower flow rates.
    Info CHAD Therapeutics, Inc.
    Customer Service: (800) 423-8870
    Web site: http://www.chadtherapeutics.com

    Related medicine products :

    1. OXYMIZER® Disposable Oxygen-Conserving Device
    2. Aestiva/5 Pendant
    3. Disposable Bipolar Pencil - 18 Gauge Curved
    4. Disposable Bipolar Pencil - 18 Gauge Straight
    5. Disposable Bipolar Pencil - 23 Gauge Tapered Tip
    6. Storz Disposable Blades
    7. Disposable Ear Knife
    8. Disposable Medical Penlight
    9. Disposable Scalp Clip Applier
    10. Disposable Electrodes
    11. Mayfield Disposable Adult (plastic) Skull Pins
    Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 1Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 2Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 3Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 4Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 5Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 6Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 57565 7TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 1TCT 2009 to Feature vProtect 28TM 29 Luminal Shield a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical 14134 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7